Taking paracetamol during pregnancy might increase the offspring's chances of developing neurodevelopmental disorders, including autism and attention deficit hyperactivity disorder, according to a study.
Available over-the-counter, paracetamol -- also known as 'acetaminophen' -- is considered safe for managing headache, fever, and pain during pregnancy.
Researchers, including those at the Icahn School of Medicine at Mount Sinai, US, analysed 46 previously published studies involving over a lakh participants across multiple countries.
Findings published in the journal BioMed Central show that "higher-quality studies are more likely to show a link between prenatal acetaminophen exposure and increased risks of autism and ADHD," said author Diddier Prada, assistant professor of population health science and policy, environmental medicine and climate science, at the Icahn School of Medicine at Mount Sinai.
"Given the widespread use of this medication, even a small increase in risk could have major public health implications," Prada said.
Biological mechanisms that could explain the link between use of paracetamol and risk of disorders in children The paper also explores biological mechanisms that could explain the association between acetaminophen use and these disorders. Acetaminophen Paracetamol is known to cross the placental barrier and may trigger oxidative stress, disrupt hormones, and cause epigenetic (gene behaviour resulting in observable traits) changes that interfere with brain development of the foetus, the researchers explained.
With cases of autism and ADHD estimated to be on an increase the world over, the findings have significant implications for public health policy, clinical guidelines, and patient education, they said.
The team added that even as the study does not show that paracetamol causes neurodevelopmental disorders in offsprings, evidence from the study strengthens the connection and raises concerns about current clinical practices.
The authors suggested a cautious, time-limited use of paracetamol by pregnant women under medical supervision and called for more studies to confirm their findings.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)